Definitive Healthcare Corp.
NASDAQ:DH
4.81 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 63.737 | 63.48 | 65.932 | 65.325 | 60.957 | 59.201 | 60.599 | 57.382 | 54.548 | 50.124 | 46.313 | 43.084 | 39.821 | 36.936 | 33.658 | 30.073 | 27.293 | 27.293 |
| Cost of Revenue
| 22.692 | 22.42 | 22.448 | 11.895 | 11.168 | 11.906 | 9.795 | 9.724 | 11.778 | 11.328 | 10.898 | 10.485 | 9.869 | 9.437 | 8.314 | 7.413 | 2.629 | 2.629 |
| Gross Profit
| 41.045 | 41.06 | 43.484 | 53.43 | 49.789 | 47.295 | 50.804 | 47.658 | 42.77 | 38.796 | 35.415 | 32.599 | 29.952 | 27.499 | 25.344 | 22.66 | 24.665 | 24.665 |
| Gross Profit Ratio
| 0.644 | 0.647 | 0.66 | 0.818 | 0.817 | 0.799 | 0.838 | 0.831 | 0.784 | 0.774 | 0.765 | 0.757 | 0.752 | 0.745 | 0.753 | 0.753 | 0.904 | 0.904 |
| Reseach & Development Expenses
| 10.122 | 10.132 | 11.569 | 10.759 | 10.229 | 9.884 | 10.129 | 9.205 | 8.706 | 6.85 | 5.748 | 4.746 | 4.277 | 3.794 | 3.496 | 2.618 | 2.474 | 2.474 |
| General & Administrative Expenses
| 12.527 | 16.883 | 16.567 | 14.545 | 13.67 | 13.64 | 15.217 | 13.718 | 9.392 | 10.454 | 11.637 | 7.88 | 6.375 | 4.636 | 4.822 | 2.538 | 2.784 | 2.784 |
| Selling & Marketing Expenses
| 21.545 | 21.76 | 23.605 | 22.804 | 24.702 | 23.423 | 23.523 | 21.184 | 23.585 | 21.293 | 17.384 | 14.376 | 12.884 | 11.743 | 10.79 | 8.292 | 7.625 | 7.625 |
| SG&A
| 34.072 | 38.643 | 40.172 | 37.349 | 38.372 | 37.063 | 38.74 | 34.902 | 32.977 | 31.747 | 29.021 | 22.256 | 19.259 | 16.379 | 15.612 | 10.83 | 10.409 | 10.409 |
| Other Expenses
| 41.6 | 2.64 | -1.982 | 29.589 | -0.797 | 9.59 | 10.04 | 10.037 | 4.002 | 9.874 | 9.865 | 9.76 | -0.1 | 0.124 | 10.16 | 10.112 | 0 | 0 |
| Operating Expenses
| 44.194 | 48.775 | 51.741 | 57.903 | 58.289 | 56.537 | 58.909 | 54.144 | 51.877 | 48.471 | 44.634 | 36.762 | 33.144 | 29.619 | 29.268 | 23.56 | 27.941 | 27.941 |
| Operating Income
| -3.149 | -7.715 | -8.257 | -295.378 | -12.071 | -12.94 | -7.298 | -0.958 | -11.214 | -9.776 | -12.174 | -4.026 | -6.623 | -2.158 | -6.952 | -0.94 | -2.923 | -2.923 |
| Operating Income Ratio
| -0.049 | -0.122 | -0.125 | -4.522 | -0.198 | -0.219 | -0.12 | -0.017 | -0.206 | -0.195 | -0.263 | -0.093 | -0.166 | -0.058 | -0.207 | -0.031 | -0.107 | -0.107 |
| Total Other Income Expenses Net
| -324.938 | -5.783 | -3.93 | -261.316 | -4.368 | -3.37 | -3.011 | -5.411 | 1.895 | -3.194 | -2.955 | -9.617 | -3.531 | 0.086 | -3.25 | -0.04 | -9.744 | -9.744 |
| Income Before Tax
| -328.087 | -13.498 | -12.187 | -266.222 | -13.089 | -16.31 | -10.309 | -6.369 | -9.792 | -12.97 | -14.089 | -20.966 | -15.039 | -10.488 | -15.862 | -9.962 | -12.667 | -12.667 |
| Income Before Tax Ratio
| -5.148 | -0.213 | -0.185 | -4.075 | -0.215 | -0.276 | -0.17 | -0.111 | -0.18 | -0.259 | -0.304 | -0.487 | -0.378 | -0.284 | -0.471 | -0.331 | -0.464 | -0.464 |
| Income Tax Expense
| -21.9 | -0.78 | 1.175 | -17.534 | -1.484 | -0.71 | -17.044 | -0.015 | -0.213 | 0.087 | 0.675 | -5.172 | 8.216 | 8.578 | 8.688 | 9.022 | -25.333 | 0 |
| Net Income
| -213.635 | -9.518 | -10.233 | -171.526 | -8.566 | -15.6 | 6.735 | -6.354 | -5.15 | -13.057 | -9.699 | -15.794 | -15.039 | -10.488 | -15.862 | -9.962 | 12.667 | -12.667 |
| Net Income Ratio
| -3.352 | -0.15 | -0.155 | -2.626 | -0.141 | -0.264 | 0.111 | -0.111 | -0.094 | -0.26 | -0.209 | -0.367 | -0.378 | -0.284 | -0.471 | -0.331 | 0.464 | -0.464 |
| EPS
| -1.81 | -0.081 | -0.088 | -1.5 | -0.077 | -0.14 | 0.064 | -0.062 | -0.052 | -0.13 | -0.1 | -0.18 | -0.17 | -0.12 | -0.18 | -0.11 | 0.145 | -0.107 |
| EPS Diluted
| -1.81 | -0.081 | -0.088 | -1.5 | -0.077 | -0.14 | 0.044 | -0.062 | -0.052 | -0.13 | -0.1 | -0.18 | -0.17 | -0.12 | -0.18 | -0.11 | 0.145 | -0.107 |
| EBITDA
| 9.639 | 4.969 | 4.744 | 38.143 | 7.053 | 0.004 | 5.388 | 12.234 | 10.669 | 5.476 | 6.018 | 10.953 | 11.615 | 12.691 | 11.342 | 14.006 | 11.782 | 11.782 |
| EBITDA Ratio
| 0.151 | 0.078 | 0.072 | 0.584 | 0.116 | 0 | 0.089 | 0.213 | 0.196 | 0.109 | 0.13 | 0.254 | 0.292 | 0.344 | 0.337 | 0.466 | 0.432 | 0.432 |